Back
Aptevo Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
20
APVO
Aptevo Therapeutics
Last Price:
$2.91
Seasonality Move:
-26.19%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.14 | Sell |
| 20-day SMA: | 3.85 | Sell |
| 50-day SMA: | 6.21 | Sell |
| 200-day SMA: | 83.23 | Sell |
| 8-day EMA: | 3.21 | Sell |
| 20-day EMA: | 3.97 | Sell |
| 50-day EMA: | 10.39 | Sell |
| 200-day EMA: | 933.32 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.24 | Sell |
| Relative Strength Index (14 RSI): | 33.93 | Sell |
| Chaikin Money Flow: | 108478 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.24 - 4.86) | Sell |
| Bollinger Bands (100): | (1.43 - 50.39) | Sell |
Aptevo Therapeutics Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 3.04 while APVO 8-day simple moving average is 3.14, which is a Sell signal.
-
The stock price of APVO is 3.04 while Aptevo Therapeutics 20-day SMA is 3.85, which makes it a Sell.
-
Aptevo Therapeutics 50-day simple moving average is 6.21 while APVO share price is 3.04, making it a Sell technically.
-
APVO stock price is 3.04 and Aptevo Therapeutics 200-day simple moving average is 83.23, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
20
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a SellThe current Aptevo Therapeutics [APVO] share price is $3.04. The Score for APVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
2M
Price in USD:
3.04
Share Volume:
130.2K
Aptevo Therapeutics 52-Week Range
52-Week High:
485.37
52-Week Low:
2.81
Sell
20
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?The Aptevo Therapeutics stock price is 3.04 USD today.
-
Will APVO stock go up or go down?Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aptevo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
-
Aptevo Therapeutics share price is 3.04 while APVO 8-day exponential moving average is 3.21, which is a Sell signal.
-
The stock price of APVO is 3.04 while Aptevo Therapeutics 20-day EMA is 3.97, which makes it a Sell.
-
Aptevo Therapeutics 50-day exponential moving average is 10.39 while APVO share price is 3.04, making it a Sell technically.
-
APVO stock price is 3.04 and Aptevo Therapeutics 200-day simple moving average is 933.32, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $346.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1,402.40 per share, and an increase next year of $27.00 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
-
APVO Moving Average Covergence Divergence (MACD) indicator is -1.24, suggesting Aptevo Therapeutics is a Sell
-
Aptevo Therapeutics Relative Strength Index (RSI) is 33.93, which suggest Aptevo Therapeutics is oversold
-
The Bollinger Bands (25) for Aptevo Therapeutics is (3.24 - 4.86), which suggest Aptevo Therapeutics is a Sell
-
The Bollinger Bands (100) for Aptevo Therapeutics is (1.43 - 50.39), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.